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Background: Lymph nodal involvement is an important clinical-pathological sign in primary cutaneous lymphoma
(PCL), as it marks the transformation/evolution of the disease from localized to systemic; therefore the surveillance
of lymph nodes is important in the staging and follow up of PCL. Fine needle cytology (FNC) is widely used in the
diagnosis of lymphadenopathies but has rarely been reported in PCL staging and follow-up. In this study an
experience on reactive and neoplastic lymphadenopathies arisen in PCL and investigated by FNC, combined to
ancillary techniques, is reported.
Methods: Twenty-one lymph node FNC from as many PCL patients were retrieved; 17 patients had mycosis
fungoides (MF) and 4 a primary cutaneous B-cell lymphoma (PBL). In all cases, rapid on site evaluation (ROSE) was
performed and additional passes were used to perform flow cytometry (FC), immunocytochemistry (ICC) and/or
polymerase chain reaction (PCR) to assess or rule out a possible clonality of the corresponding cell populations.
Results: FNC combined with FC, ICC, and PCR identified 12 cases of reactive, non specific, hyperplasia (BRH),
4 dermatopathic lymphadenopathy (DL), 4 lymph nodal involvement by MF and 1 lymph nodal involvement by
cutaneous B-cell lymphoma.
Conclusions: FNC coupled with ancillary techniques is an effective tool to evaluate lymph node status in PCL
patients, provided that ROSE and a rational usage of ancillary techniques is performed according to the clinical
context and the available material. The method can be reasonably used as first line procedure in PCL staging and
follow up, avoiding expensive and often ill tolerated biopsies when not strictly needed.
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Primary cutaneous lymphomas (PCL) are the second most
common extra-nodal non Hodgkin lymphomas (NHL)
and represent a broad spectrum of distinct entities with
different pathological presentations, clinical behaviours
and treatment options [1]. Corresponding WHO/EORTC
classification [1,2] accounts for approximately 20 distinct
clinical-pathological entities, mainly divided into three
diagnostic categories, namely cutaneous T-cell and/or
NK-cell lymphoma, cutaneous B-cell lymphoma and pre-
cursor haematological neoplasm. As far as the staging of
PCL is concerned, the TNM AJCC/UICC staging system* Correspondence: pzeppa@unisa.it
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reproduction in any medium, provided the or[3,4] and the most recent TNM ISCL/EORTC staging sys-
tem [5,6] identify three different parameters: the extension
and characteristic of skin lesions, lymph nodal involve-
ment and extra-cutaneous diffusion. Lymph nodal in-
volvement represents an important clinical-pathological
sign that marks the transformation/evolution of the dis-
ease from localized to systemic; therefore, PCL patients
are closely observed for the possible development of
palpable lymphadenopathies. Whereas the evidence of
palpable lymph nodes alone determines the N1 stage in
the histopathological staging of mycosis fungoides (MF)
and Sézary syndrome (SS) [5], in clinical practice surgical
excision and histological evaluation are generally applied
to assess potential lymph nodal involvement by corre-
sponding diseases [5]. Nonetheless, many PCL have a long
standing clinical course [7] in which lymph nodaltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Vigliar et al. BMC Cancer 2014, 14:8 Page 2 of 10
http://www.biomedcentral.com/1471-2407/14/8enlargement may arise at any time and for different rea-
sons. For instance the incidence of dermatopathic lym-
phadenitis (DL) is higher in PCL patients than in others,
but surgical excision is not easily performed or well
accepted by the patients and surgical biopsy for diagnostic
purposes alone might be considered an excessive solution/
over-intervention in cases of unspecific benign reactive
hyperplasia (BRH) or DL. Fine needle cytology (FNC),
combined with different ancillary techniques, has gained a
definitive role in the diagnosis of lymphadenopathies [8,9]
although only few studies have explored a possible role for
FNC in lymph nodal evaluation in the management of
PCL [10,11]. These studies have investigated the possi-
bilities of employing FNC exclusively in MF/SS [10,11]
mainly focussing on PCR assessment of lymph nodes
highly suspected or clinically involved by PCL. Nonethe-
less, we found that, in this specific clinical setting, lymph
nodal FNC presents problems related to sampling, amount
of cells obtained, variable cytological features, and the
application of ancillary techniques. In our Institution FNC
is generally requested for all enlarged lymph nodes that
arise in patients suffering from any type of neoplasm, cli-
nically or US suspected for malignancy. In this study weTable 1 Clinical, cytological, phonotypical and molecular data
cutaneous lymphoma (PCL) patients
Case n° Clinical data Lymph node site FC
1 MF/SS Inguinal Monoclonal
2 MF Axillary Polyclonal
3 NHL B Laterocervical NC
4 NHL B Axillary NC
5 MF Axillary Polyclonal
6 MF Axillary NC
7 MF Inguinal Polyclonal
8 MF Laterocervical NC
9 MF Inguinal Polyclonal
10 NHL B Axillary NC
11 MF Axillary Polyclonal
12 MF Inguinal NC
13 MF Laterocervical NC
14 MF Laterocervical Monoclonal
15 NHL B Axillary Monoclonal
16 MF Axillary Polyclonal
17 MF Inguinal polyclonal
18 MF Axillary Polyclonal
19 MF Inguinal NC
20 MF Laterocervical Polyclonal
21 MF Laterocervical Polyclonal
MF: mycosis fungoides; BRH: benign reactive non-specific hyperplasia; DL: dermatopreport our experience with FNC combined with ancillary
techniques, on reactive and neoplastic lymphadenopathies
arisen in PCL, including B-cell PCL. The aim of this study
was to evaluate the possible role of lymph nodal FNC
coupled with ancillary techniques in the staging and
follow-up of PCL.
Results
FNC combined with ancillary techniques (FC, ICC,
PCR) provided the following diagnoses: 12 BRH, 4 DL, 4
lymph nodal involvement by MF and 1 by cutaneous
B-cell lymphoma. Cytological features of the present
series were quite variable and four main patterns were
identified. The clinical, cytological, phonotypical and
molecular data are summarized in Table 1.
Reactive, non-specific hyperplasia
The FNC of reactive lymph nodes was quite similar in all
cases, showing a variable mixture of normal cell type con-
stituents and differing only in the amount of cells. The
latter were mature small lymphocytes, follicular centre
cells and reticular cells. Small lymphocytes were recognis-
able because of their size, round or elongated shape andof 21 lymph node fine needle cytology (FNC) of primary













CD3+; CD20+ NP DL
NP Monoclonal MF




UCHL1(CD45RO)+; CD3+ Monoclonal MF
NP NP BRH
NP NP BRH
athic lymphoadenopathy, NC: not contributive; NP: not performed.
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medium sized and irregular in shape (centrocytes) or lar-
ger and roundish, with a bluish cytoplasm rime and nuclei
with granular chromatin and two or more nucleoli (cen-
troblasts and immunoblasts). Reticular cells were always
present; nuclei were large with clumped chromatin
and wide and pale cytoplasm. Vascular structures and
phagocytic histiocytes were also present, conferring a
polymorphous appearance to the smear. When a lymph-
adenopathy was determined by the expansion of the fol-
licular centres, the smears showed numerous centrocytes
and centroblasts intermingled with small mature lympho-
cytes, plasma cells and immunoblasts. In cases of inter-
follicular expansion the smears showed a prevalence of
mature lymphocytes, plasma cells and immunoblasts; scat-
tered epithelioid cells were occasionally present. In oneFigure 1 Case 17, dermatopathic lymphadenopathy. A: FNC smear of d
dispersed cell population represented by small lymphocytes, scattered hist
lymphocytes with compact chromatin and histiocytes with vesicular nuclei
and CD2/3/7 co-expression assessing the polyclonality of the T-cell populatio
multiple peaks, in a shape similar to a Gaussian curve, assessing the polyclonacase, groups of epithelioid cells organized in small granu-
lomatous structures were detected and diagnosed.
Dermatopathic lymphadenopathy
Smears from lymph nodes with DL were quite cellular,
with increased number of histiocytoid-dendritic cells
(Figure 1A), sometimes clustered around vascular struc-
tures. These histiocytoid cells had abundant, pale blue
cytoplasm, with indistinct cytoplasmic borders. The nuclei
were elongated and vesicular with a fine chromatin pat-
tern and irregular borders (Figure 1B). Nuclear grooves
were rarely observed; macrophages containing brown
melanin pigment were also observed. Mature lympho-
cytes, eosinophils and plasma cells were present in the
background. Follicular centre cells were scantily repre-
sented in comparison with BRH cells.ermatopathic lymphadenopathy: the smear shows a polymorphous
iocytes and occasional eosinophils (Diff Quik stain 430X). B: Small
(Papanicolaou stain 430X). C: FC showing balanced CD4/CD8 ratio,
n. D: DHPLC chromatogram of the TCRγ amplification product showing
l status.
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FNC of the lymph nodes involved by MF showed a large
number of medium sized cells with dense chromatin and
irregular shape; the nucleoli were not easily detectable by
either Papanicoplaou or Diff Quik stain (Figure 2A).
Nuclear borders were irregular and seldom showed evi-
dent deep cleavages or histologically detectable foldings
(Figure 2B). Background was polymorphous, consisting
in small lymphocytes, reticular cells, and eosinophils
(Figure 2A).
B-cell lymphoma
One case (case 15), diagnosed as B-cell lymphoma, had a
history of large cell cutaneous B-cell lymphoma. TheFigure 2 Case14, lymph nodal involvement by MF. A: FNC smear of lym
medium sized cells with dense coarse chromatin. In the background there
270X). B: Atypical lymphoid cells with nuclear irregularities, with lymphocyt
absence of CD8 cells and loss of CD7 in the same CD3/CD2 positive cells. D
single peak assessing the monoclonal status. Sanger electropherogram of t
of sequence. Blast analysis indicated the homology between this sequence
IMGT® databases.smear showed a relative monomorphous cell population
of medium-large sized lymphoid cells with clumped
chromatin and one or two nucleoli (Figure 3A); reticular
cells, large follicular centre cells and macrophages were
practically absent.
Flow cytometry findings
FC assessment was successful in 13 cases, whereas, due
to scanty cellularity, it was inadequate in the remaining
8. Of the adequate cases, 10 were reactive, 2 MF, and
one B-cell NHL. All the cases of BRH and DL showed a
normal CD4:CD8 ratio (3:1, 4:1) with T-cell surface anti-
gens (CD2/CD3/CD7) co-expression (Figure 1C). B-cell
antigens were also expressed, as was a variable amountph nodal involvement by MF showing an atypical cell population of
are mature lymphocytes and numerous eosinophils (Diff Quik stain
es and eosinophils in the background. C: FC showing the complete
: DHPLC Chromatogram of the TCRγ amplification product showing a
he TCRγ amplification product from the same case showing one type
and the germline Vg4-Jg1/2 rearrangement as in the
Figure 3 Case 15, lymph nodal involvement from cutaneous B-cell lymphoma. A: FNC smear of lymph nodal involvement from cutaneous
B-cell lymphoma showing monomorphous large lymphoid cells with immature chromatin and two or more large nucleoli (Diff-Quik stain 430 X).
B: FC showing CD10/19 co-expression and the kappa light chain restriction.
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which FC was not effective, ICC was performed showing
proportional expression of CD3 and CD20. In particular,
the large cells present in the smear were CD20 positive,
confirming their B-cell origin. In two cases of lymph nodal
involvement by MF (cases 1 and 14) FC showed an ab-
normal CD4/CD8 ratio (>10:1) and loss of CD7 expres-
sion (Figure 2C). In the remaining 2 cases (cases 6 and 19)
FC was not effective, and ICC, performed on additio-
nal smears, showed UCHL1 and CD3 positivity in the
medium-large sized cells with deep nuclear cleavages. In
the lymph node involved by B-cell lymphoma (case 15),
FC showed B-cell antigen over-expression, CD10 nega-
tivity and kappa light chain restriction (Figure 3B).TCRγ molecular analysis
In patients 3 and 17, the DHPLC analysis displayed a
Gaussian distribution of amplified products (Figure 1D),
while the blast analysis of the sequencing products ob-
tained showed three productive rearrangements (Vγ4-Jγp,
Vγ2-Jgp and Vγ4-Jg1) and one non rearranged Vγ8 seg-
ment, asserting the polyclonality of the corresponding
T-cell population. Molecular analysis confirmed the mo-
noclonal status in cases 14 and 19, showing single peaks
at the DHPLC analysis (Figure 2D). Blast analysis of the
sequencing products obtained showed the productive
Vγ4-Jγ1/2 and the unproductive Vγ3-Jγ1/2 rearrange-
ments, as illustrated in Figure 1B. Cytological diagnoses
were confirmed by histology in positive cases, except in
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evidence of systemic disease, and in two benign DL cases
(cases n. 5, 11) for whom ancillary techniques were not
performed and there was disagreement with the clinical
orientation. As for the remaining 14 negative cases, the
patients underwent clinical and US follow-up. Follow-up
time ranged between 5 years and 10 months, during which
the cytological diagnoses were confirmed by reduction or
persistence without increase in size or modifications of
the US features of the corresponding lymph nodes.
Discussion
Lymph node evaluation is an important step in the sta-
ging, prognosis and follow up of PCL, although there are
differences in lymph nodal involvement between B-cell
and T- cell lymphoma. Indeed, according to the TNM
ISCL/EORTC staging system [5,6], in case of cutaneous
B-cell lymphoma, microscopic evidence of regional lymph
node involvement determines the transition from N0 to
N1, N2 or N3 staging, depending on the peripheral re-
gion/s or central lymph node involvement respectively [6].
In case of MF and SS, the evaluation of the lymph nodes
is different; in fact, because of the negative impact on sur-
vival rates of “palpable adenopathy”, their clinical evidence
alone determines the transition from N0 to N1 staging [5].
This is a critical point in the management of MF/SS pa-
tients because the change in staging determines the need
for systemic therapy; therefore, in clinical practice, histo-
logical evaluation can be requested. Criteria for lymph
node removal in PCL staging are clinical and dimensional:
the ISCL/EORTC revision [5] defines as clinically abnor-
mal peripheral nodes in MF/SS those measuring 1.5 cm or
more in the longest transverse diameter, or any palpable
peripheral node, regardless of size, that on physical exa-
mination is firm, irregular, clustered, or fixed [5]. The
1.5-cm size is different from the 1-cm diameter node des-
ignated as abnormal in the ISCL/EORTC staging for non-
MF/SS primary cutaneous lymphomas, since BRH or DL
commonly occur in MF/SS, but arise less frequently in
B-cell PCL [6]. These enlarged or clinically abnormal
lymph nodes should also be evaluated by ultrasonography
(US), computed tomography (CT) and 18 F-fluorodeoxy-
glucose positron emission tomography (FDG-PET) [5,6].
In cases of multiple lymph adenopathies, the guidelines
suggest the biopsy of the cervical or axillary nodes first,
and then the inguinal ones [5,12], according to the dif-
ferent probabilities of involvement. As for the lymph node
status, both the Dutch and NCI-VA classifications [5]
depended on their architecture and hence on histological
evaluation. Therefore lymph node excision was the only
considered procedure for this specific purpose. Nonethe-
less, simple histology too is not always effective; in the
Fraser-Andrews’ study six of 19 patients with uninvolved
lymph nodes or limited histological involvement (LN0-2)had a detectable T-cell clone at PCR investigation [13].
Moreover excisional lymph node biopsies are not always
easily performed and may be complicated by sepsis in
immunodepressed, especially erythrodermic patients [5].
Therefore the same guidelines suggest considering FNC as
a possible diagnostic procedure for lymph node assess-
ment possibly coupled with ancillary techniques [5]. Not-
withstanding, relatively few studies have investigated the
possible contribution of FNC in lymph nodal investigation
in PCL [10,11] probably because of the problem of lymph
nodal FNC false negatives that may arise in other neo-
plasm. In fact FNC false negatives mainly concerns lymph
nodes involved by neoplasm that determine partial and
sub-capsular metastases, such as breast carcinoma and
melanoma [14,15]. In these cases, the needle may not suc-
ceed in sampling the specific involved areas of the lymph
node, producing false negatives. Nonetheless, lymph node
partial involvements is less frequently observed in haem-
atological neoplasm [16] including cutaneous lymphoma.
Moreover, according to the standardized cytological tech-
niques of sampling, we moved the needle in different di-
rections, during the FNC sampling, in order to reach
different areas of the lymph node and to increase the
probabilities of a representative sampling. Finally small
cell clones may be not detected by FC but, in some CL,
nuclear atypia are quite evident to be identified at the
microscopic examination of the smears and by ICC, even
though in small number. In the present study, although
the basic approach of the technique was the same as that
used in lymph nodal FNC from different contexts [8], spe-
cific problems were encountered mainly due to the differ-
ent sites of development and clinical presentation. In fact,
it was either impossible, or hardly possible, to perform
FNC under US control on axillary lymph nodes due to
their “mobility” and to the anatomical peculiarity of the
axillary hollow which does not provide enough room for
the US probe and the lateral needle holder, or even for the
needle cap to guide the needle. Therefore, in our ex-
perience, palpable axillary lymph nodes were better ap-
proached by “pulling down” the node with the index and
middle fingers and blocking it on the thoracic wall. One of
the fingers was then used as a support for the needle while
carrying out the sampling with or without aspiration. The
second problem was presented by erythrodermic patients
who are generally more sensitive than others, and often
suffer from cold and have fragile skin that easily bleeds.
Therefore lymph nodal sampling was performed quite
rapidly on these patients, with no more than one ad-
ditional pass and with careful capitalization of the mate-
rial. For the above mentioned reasons, in our Department,
ROSE is generally performed on lymph node FNC and
always on PCL patients. This methodology, in addition to
assessing the adequacy of the smear, allows a correct
management of the material obtained according to the
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for small-medium sized cell populations, cell suspension
in buffered solution for FC and PCR was generally pre-
ferred. Conversely, in case of large cell populations ad-
ditional alcohol fixed smears were preferred for ICC
phenotypization. Therefore we believe that the “petals”
largely compensate for the “thorns” that ROSE offers in
this contexts [17]. In the study by Pai et al. [11] the cell
block technique was used for ICC; in our laboratory cell
block is highly effective in different cytopathological con-
texts but, in this specific series, since we did not obtain
sufficient cellularity in the first two cases, we preferred to
utilize residual material for other ancillary techniques. As
for the positive cases, the cytological features observed
were quite similar to those described by Pai et al. [11], and
represent the only other extensive cytological description
of lymph nodal MF/SS available, apart from the present
one. However, we did not observe the predominant small-
cell pattern as the one described by these authors. Ancil-
lary techniques are basic tools in the cytological diagnosis
of lymphoproliferative processes [8,9,18-20]; according to
Galindo [10] and Pai [11] they are fundamental in this
specific context, whereas we believe that some points
should be discussed. In our experience, according to
Galindo et al. [10] and Pai et al. [11], FC by CD4/CD8
ratio and the quantitative evaluation of CD7 still seems to
be the most effective procedures, provided that a sufficient
amount of cells is collected. Even in the case of lymph
node involvement by B-cell PCL, FC was effective in de-
monstrating the B-cell phenotype and the corresponding
light chain restriction as in the corresponding primary
NHL. Nonetheless, in the present series FC was not effec-
tive in 8 out of 21 cases; this performance was definitely
less effective than that observed in other FNC/FC lymph
nodal series [8,9] and other procedures had to be applied.
This finding hampers the comparison of the different ap-
plied techniques and should be not be surprising too; in
fact in case of large diagnostic cell populations as the case
of small cell B or T-NHL the procedure is highly effective
[8,9]; conversely when diagnostic cells are relatively scanty
and intermingled among benign reactive cells FC is pro-
portionally less effective [8,9]. This is the case of Hodgkin
lymphoma or anaplastic large cells and some high-grade
T-cell lymphoma in which diagnostic cells are too scanty
to be gated or being too large, they stick to the tubes of
the equipment or get broken or lost determining false
negative results. In these cases, conversely even few cells
detected on light microscope may be sufficient for a de-
finitive diagnosis, therefore other ancillary techniques had
to be used. For instance, in 3 cases of scanty cellularity,
ICC on additional smears was more effective than FC,
allowing the identification of large atypical T-cell cells that
were too scanty to be analyzed by FC. As for molecular
testing, TCR-PCR is the most sensitive technique to assessT-cell clonality but also carries a relatively high rate of
false positives [21]. In the study by Galindo et al. [10]
there was total agreement between cytological FC and
TCR on cytological samples in terms of both sensitivity
and specificity. Conversely, in the same study, tissue/TCR
was highly sensitive but less specific, as it detected three
reactive lymph nodes as clonal [10]. Pai et al. [11] detected
T-cell clonal population by TCR-γ PCR in two cases and,
as expected, negativity in two Hodgkin lymphoma. In our
cases TCR-PCR was performed on cytological material
only in 4 cases and was also in agreement with the cyto-
logical/FC data. In addition to Galindo’s experience [10], a
rate of false positive respectively of 3.6 and 5.4% for fresh
and paraffin-embedded tissues was reported [21]. In a
study performed on peripheral blood of MF and SS
patients a 34% positivity rate on patients with benign cuta-
neous infiltrate was detected [22]. Therefore, as FNC is in-
evitably contaminated with peripheral blood, TCR-γ PCR
should be carefully evaluated in this regard. Considering
the dramatic evolution of molecular technologies, it is
easy to foresee that highly sensitive and accurate proce-
dures will shortly overcome specificity problems.
Conclusion
Notwithstanding histology is the gold standard in lymph
node evaluation and a larger comparative study between
the two methods assessing their concordance is still
compulsory, FNC might be considered as a first step
procedure in PCL staging. FNC coupled with ROSE and
ancillary techniques, utilized according to the clinical
context and the available material, might be utilized to
reinforce the negative diagnoses based on clinical and or




From the files of the Cytopathology Service of the Depart-
ment of Pathology, of the “Federico II” University of
Naples, twenty-one lymph nodal FNC from PCL patients,
performed over a 7-year period between January 2004 and
December 2011, were retrieved. The study was approved
by the Ethics Committee of the Istituto Nazionale Tumori
Fondazione "G. Pascale" of Naples, Italy. At the time of
FNC, patients were informed of the diagnostic procedure
and its related risks; informed consent for the FNC per-
forming, the diagnostic procedures and the scientific use
of biological material was obtained from all the patients.
No children were included in the study. Patients’ ages
ranged from 39 to 71 years (mean age 55 yrs); 17 patients
suffered from MF and 4 patients from a primary cutane-
ous B-cell lymphoma. The time from the first diagnosis to
lymph nodal FNC ranged from three to 47 months. Sites
of lymph nodes were: 6 cervical, 9 axillary, and 6 inguinal.
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tigation; all were eventually US evaluated. The sizes
ranged between 12 and 30 mm. Clinical data are sum-
marized in Table 1.
At the time of FNC, patients were informed of the diag-
nostic procedure and its related risks; informed consent
for the FNC performing, the diagnostic procedures and
the scientific use of biological material was obtained from
all the patients. No children were included in the study.
Nine FNC were performed under US control and 12 by
palpation and blocking the lymph node between the
fingers. This was the case of 7 axillary lymph nodes in
which US assisted FNC was difficult or impossible. Two
patients showed different degrees of exfoliative erithro-
derma; therefore extreme care was taken in performing
FNC in their case. Moreover in these patients the proce-
dure was troubled by variable degree of pain on palpation,
sensations of cold, and bleeding disproportionate to the
gauge of the needle. According to the standardized cyto-
logical technique of sampling, we moved the needle in
different directions during the FNA in order to reach dif-
ferent areas of the lymph node and to increase the pro-
babilities of a representative sampling. The first smear was
Diff-Quik stained for rapid on-site evaluation (ROSE) [17]
of the adequacy of the sample; the remaining material left
in the hub of the needle was carefully flushed with
phosphate-buffered saline solution (PBS) and added, when
necessary to a second pass in cases of scanty cellularity
and used for flow cytometry (FC). When possible and
according to ROSE cytological features, additional alco-
hol-fixed smears were used for Papanicolaou stain or con-
ventional immunocytochemistry (ICC). In four cases a
further pass was suspended in RNAlater TM for molecu-
lar investigation. In two cases residual cell suspensions
were used to prepare cell-blocks but sections with suffi-
cient cellularity were not obtained.
Flow cytometry
Cell suspensions were processed within two hours; they
were washed twice by centrifugation for 4’ at 2500 rpm,
after which the supernatant was removed and added to
400 μL of PBS. When a sufficient amount of cells was
available, the final suspension was divided into four or
more tubes. One or two tubes of cell suspensions were
stored until the end of the procedure in order to have
additional material available in cases of unsatisfactory re-
sults or if further tests were needed. All the samples
were then incubated for 15 minutes in the dark with
10 μL of the following basic combinations of phyco-
erythrin (PE), perdin chlorophyll protein (PERCP) and
fluorescein isothiocyanate (FITC) antibodies: CD3, CD2,
CD4/8, CD2/3/7, CD5/10/19, CD19/κ/λ, FMC7/CD23/
CD19, CD38/56/19. All antibodies were purchased from
Becton Dickinson (San José, CA) except for bcl-2, whichwas purchased from Pharmingen. After incubation red
blood cells were lysed with ammonium chloride lysing so-
lution (diluted to 10%) for 5 minutes and then washed
twice. If small fragments were still present, the suspension
was filtered through 50-micron filters; finally an equal part
of 1% paraformaldehyde was added to each tube for cell
fixation. When the routine technique failed to detect
intra-cytoplasmatic light chains on the surface, cells were
suspended in permeabilizing solution and incubated for
30’ in the dark. FC was then performed using a three-
color analysis technique on a Becton Dickinson (San José,
CA) FACS scan as previously described [9]. As far as the
data evaluation is concerned, an antibody was considered
expressed when a minimum of 10% of the gated cells were
positive. Clonality assessment for T-cell process was estab-
lished according to the ISCL/EORTC immunophenotypic
criteria for the diagnosis of peripheral blood involvement
by cutaneous T-cell lymphoma, because there are no simi-
lar criteria for FC in lymph node samples. The ISCL/
EORTC criteria are: 1) >40% of CD + T-cells exhibit loss
of CD7 or >30% of CD + T-cells exhibit loss of CD26, 2)
CD4:CD8 ratio greater of 10:1, and/or 3) aberrant expres-
sion of multiple pant-cell surface markers [5,11,12]. In
light chain evaluation, κ:λ ratios greater than 4:1 or 1:2
were considered as definite evidence of monoclonality
[18-20]. In cases of equivocal results or technical difficul-
ties, residual material, stored in a tube at 4°C, was suitable
for further analysis within 24 hours from sampling.
Immunocytochemistry
Immunocytochemical stains were performed in three
cases, using additional 95° alcohol-fixed smears; the pri-
mary antibodies used were UCHL1 (CD45RO), CD3 and
CD20 (1:100; Dakopatts, Glostrup, Denmark). This pro-
cedure has been previously described [8,9].
Molecular analysis
DNA extraction
In the four cases processed, sufficient high molecular
weight DNA was extracted from the cells using a com-
mercially available kit (QIAamp DNA Mini Kit, QIAGEN)
according to the manufacturer’s instructions. Samples
were centrifuged at 1300 rpm for 20 minutes to expel the
RNAlater TM. After discharge of the supernatant, 20 μl of
Proteinase K were added to each sample and incubated at
50°C for 3 hours. After a second incubation at 70°C for 10’
in 200 μl of Buffer AL, 200 μl ethanol (96-100%) were
added; the mixture was then loaded onto a QIAamp Spin
Column and centrifuged at 8000 rpm for 1’. The column
was then washed with 500 μl l Buffer AW1 by centrifuga-
tion at 8000 rpm for 1’ and with 500 μl l Buffer AW2 by
centrifugation at 14000 rpm for 3’. When all the residual
ethanol had been removed, DNA was eluted with 70 ml
Buffer AE by centrifugation at 8000 rpm for 1 minute.
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One hundred ng of genomic DNA from each patient were
amplified using two multiplex mixes that independently
target preserved framework regions of the variable and
joining regions of TCR γ chain locus that flanks the
antigen-binding, complementarity determining region 3
(CDR3). The limit of confidence in the detection of this
assay is approximately one clone T-cell among one hun-
dred normal cells. Mix 1 contained the primers Vγ1-8,
while mix 2 contained the primers Vγ 5-10-11-12. PCR
was performed using GoTaq® Green Master Mix (Promega,
cat n. M7123), as indicated by the manufacturer, supplied
by 0.4 μM of each primer. PCR reactions were performed
with a Veriti® Thermocycler (Applied Biosystems) by incu-
bating samples at 94°C for 7’, followed by 45 cycles of 95°C
for 1’, 55°C for 1’, 72°C for 1’. The final extension step was
performed for 10’ at 72°C and the samples were then
chilled to 4°C. The PCR products generated from TCRγ
assay were identified using a standard gel electrophoresis
with ethidium bromide staining. Clonality was indicated
when one of the multiplex mixes generated clonal band(s)
of almost 190 bp, with a normal distribution of product
sizes between 159 and 260 nucleotides [23,24].
Heteroduplex analysis and Denaturing High Performance
Liquid Chromatography (DHPLC) analysis
Heteroduplex analysis was performed on PCR products at
high temperature and rapid re-annealing of the DNA
strands by immediate temperature reduction. This pro-
cedure causes a large portion of DNA strands to bind in-
correctly to other non-homologous strands, creating DNA
loops that cause significant reduction in the DNA capacity
to migrate through the DHPLC column. Therefore, in the
clonal samples with a polyclonal background, the hetero-
duplex analysis caused an increase in their separation and
allowed the identification of the clonal TCRs. In the fol-
lowing DHPLC analysis the clonality status of each pro-
duct was evaluated by Denaturing High Performance
Liquid Chromatography on a Transgenomic WaveTM
System Model 3500HT (DHPLC, Transgenomic TM,
Omaha, NE, USA) on a high resolution micropellicular
matrix. Elution profiles were performed at 50°C (native
DNA). Ten μl samples were injected into a preheated
(50°C) C18 reversed-phase column with non-porous
polystyrene-divinylbenzene particles (DNA Sep, Transge-
nomic). The injected sample was eluted with a linear aceto-
nitrile gradient consisting of buffer A (0.1 mol/L TEAA)
and buffer B (0.1 mol/L TEAA, 250 mL/L acetonitrile) with
a 2% increase in buffer B per minute. PCR products were
separated with a flow rate of 0.9 mL/min and retention
time was measured online via ultraviolet absorbance at
254 nm in the elute. The resulting diagrams showed ab-
sorbance intensity in millivolts over the retention time in
minutes (mV/min) after injection into the column. In thisway, the DNA isolated from a heterogeneous population
of polyclonal T-cells produces a Gaussian distribution
(bell-shaped curve) of amplified product on HA or DHPLC
analysis, whereas a monoclonal population will generate a
single peak of elution.
Sequencing analysis
The PCR amplicons were sequenced in both directions by
the Sanger method. The identification of rearranged genes
was performed by comparing the sequences obtained with
the germline sequences available in the IMGT® databases
(http://imgt.cines.fr; European Bioinformatics Institute,
Montpellier, France).
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